CBL0137 Increases the Targeting Efficacy of Rovalpituzumab Tesirine against Tumor-Initiating Cells in Small Cell Lung Cancer

Researchers investigated the potential effect of combining Rovalpituzumab tesirine and CBL0137 in small cell lung cancer to eradicate tumor-initiating cells more effectively.
[British Journal of Cancer]
Lindner, D. J., Wildey, G., Parker, Y., Dowlati, A., Stark, G. R., & De, S. (2020). CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer. British Journal of Cancer, 1–3. https://doi.org/10.1038/s41416-020-01192-x Cite
Abstract
Bookmark

No account yet? Register

0
Share

Nitric Oxide-Targeted Therapy Inhibits Stemness and Increases the Efficacy of Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Researchers explored whether targeting nitric oxide in estrogen positive breast cancer cells impacts cancer stem cell subpopulation and sensitivity to hormonal therapy with tamoxifen.
[Laboratory Investigation]
López-Sánchez, L. M., Mena, R., Guil-Luna, S., Mantrana, A., Peñarando, J., Toledano-Fonseca, M., Conde, F., De la Haba-Rodríguez, J. R., Aranda, E., & Rodríguez-Ariza, A. (2020). Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells. Laboratory Investigation, 1–12. https://doi.org/10.1038/s41374-020-00507-z Cite
Abstract
Bookmark

No account yet? Register

0
Share

Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity

Mitochondrial inhibition may be a viable strategy for eradicating cancer stem cells. Medicinal chemistry research over the last decade has synthesized and characterized “vehicles” capable of transporting novel or existing pharmacophores to mitochondrial tumor cells, based on mechanisms that exploit the physicochemical properties of the vehicles and the inherent properties of the mitochondria.
[International Journal of Molecular Sciences]
Catalán, M., Olmedo, I., Faúndez, J., & Jara, J. A. (2020). Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity. International Journal of Molecular Sciences, 21(22), 8684. https://doi.org/10.3390/ijms21228684 Cite
Full ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

The Effect of Calcium Electroporation on Viability, Phenotype and Function of Melanoma Conditioned Macrophages

Researchers showed the effect of calcium electroporation on immune cells, using melanoma-conditioned bone marrow-derived macrophages.
[Scientific Reports]
Tremble, L. F., Heffron, C. C. B. B., & Forde, P. F. (2020). The effect of calcium electroporation on viability, phenotype and function of melanoma conditioned macrophages. Scientific Reports, 10(1), 20645. https://doi.org/10.1038/s41598-020-77743-2 Cite
Full Article
Bookmark

No account yet? Register

0
Share

In Silico and In Vitro Studies on the Anti-Cancer Activity of Andrographolide Targeting Survivin in Human Breast Cancer Stem Cells

Human CD24/CD44+ breast cancer stem cells (BCSCs) were treated with andrographolide in vitro for 24 hours. The cytotoxic effect of andrographolide on BCSCs was compared to that on human mesenchymal stem cells.
[PLoS One]
Wanandi, S. I., Limanto, A., Yunita, E., Syahrani, R. A., Louisa, M., Wibowo, A. E., & Arumsari, S. (2020). In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells. PLOS ONE, 15(11), e0240020. https://doi.org/10.1371/journal.pone.0240020 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Histone Demethylase JMJD2D Promotes the Self-Renewal of Liver Cancer Stem-Like Cells by Enhancing EpCAM and Sox9 Expression

Investigators showed that histone lysine demethylase 4D (JMJD2D) expression was increased in liver cancer stem-like cells (LCSCs); downregulation of JMJD2D inhibited the self-renewal of LCSCs in vitro and in vivo and inhibited the lung metastasis of LCSCs by reducing the survival and the early lung seeding of circulating LCSCs.
[Journal of Biological Chemistry]
Deng, Y., Li, M., Zhuo, M., Guo, P., Chen, Q., Mo, P., Li, W., & Yu, C. (2020). Histone demethylase JMJD2D promotes the self-renewal of liver cancer stem-like cells by enhancing EpCAM and Sox9 expression. Journal of Biological Chemistry, jbc.RA120.015335. https://doi.org/10.1074/jbc.RA120.015335 Cite
AbstractFull Article
Bookmark

No account yet? Register

0
Share

EMT, Cancer Stem Cells and Autophagy; the Three Main Axes of Metastasis

The authors investigate and elucidate the relationship between the effective signaling pathways in CSCs, autophage, and epithelial-mesenchymal transition, which could play an effective role in determining appropriate therapeutic goals.
[Biomedicine & Pharmacotherapy]
Babaei, G., Aziz, S. G.-G., & Jaghi, N. Z. Z. (2021). EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomedicine & Pharmacotherapy, 133, 110909. https://doi.org/10.1016/j.biopha.2020.110909 Cite
AbstractGraphical Abstract
Bookmark

No account yet? Register

0
Share

Hepatocellular Carcinoma: Intratumoral EpCAM-Positive Cancer Stem Cell Heterogeneity Identifies High-Risk Tumor Subtype

Scientists investigated the spatial heterogeneity of cancer stem cell-features with the aim of identifying the unique hepatocellular carcinoma patient subgroups amenable to adjuvant treatment.
[BMC Cancer]
Krause, J., von Felden, J., Casar, C., Fründt, T. W., Galaski, J., Schmidt, C., Jung, C., Ittrich, H., Weidemann, S. A., Krech, T., Heumann, A., Li, J., Fischer, L., Sauter, G., Lohse, A. W., Wege, H., & Schulze, K. (2020). Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype. BMC Cancer, 20(1), 1130. https://doi.org/10.1186/s12885-020-07580-z Cite
Full Article
Bookmark

No account yet? Register

0
Share

A Stem Cell Reporter Based Platform to Identify and Target Drug Resistant Stem Cells in Myeloid Leukemia

Investigators showed that a knock-in reporter mouse for the stem cell gene Musashi 2 allowed identification of leukemia stem cells in aggressive myeloid malignancies, and provided a strategy for defining their core dependencies.
[Nature Communications]
Spinler, K., Bajaj, J., Ito, T., Zimdahl, B., Hamilton, M., Ahmadi, A., Koechlein, C. S., Lytle, N., Kwon, H. Y., Anower-E-Khuda, F., Sun, H., Blevins, A., Weeks, J., Kritzik, M., Karlseder, J., Ginsberg, M. H., Park, P. W., Esko, J. D., & Reya, T. (2020). A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia. Nature Communications, 11(1), 5998. https://doi.org/10.1038/s41467-020-19782-x Cite
Full Article
Bookmark

No account yet? Register

0
Share

Clonal Hematopoiesis before, during, and after Human Spaceflight

Researchers analyzed clonal hematopoiesis (CH) in blood samples from a pair of twin astronauts over four years in bulk and fractionated cell populations using a targeted CH panel, linked-read whole-genome sequencing, and deep RNA sequencing.
[Cell Reports]
Trinchant, N. M., MacKay, M. J., Chin, C., Afshinnekoo, E., Foox, J., Meydan, C., Butler, D., Mozsary, C., Vernice, N. A., Darby, C., Schatz, M. C., Bailey, S. M., Melnick, A. M., Guzman, M., Bolton, K., Braunstein, L. Z., Garrett-Bakelman, F., Levine, R. L., Hassane, D., & Mason, C. E. (2020). Clonal Hematopoiesis Before, During, and After Human Spaceflight. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2020.108458 Cite
Full ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53

Using Western blotting and qRT-PCR analyses, investigators revealed that in the T47D and BT20 breast cancer cell lines, astaxanthin inhibited expression of pontin and mutp53, as well as the Oct4 and Nanog cancer stem cell stemness genes.
[Marine Drugs]
Ahn, Y. T., Kim, M. S., Kim, Y. S., & An, W. G. (2020). Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53. Marine Drugs, 18(11), 577. https://doi.org/10.3390/md18110577 Cite
Full Article
Bookmark

No account yet? Register

0
Share
Share